Companies / CinCor Pharma, Inc.
CinCor Pharma, Inc.
CINCCIK 1868734
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | General Atlantic Genpar (Bermuda), L.P. 10% owner | Buy Open-market buy | Common Stock | $27.20M | +1.7M +70.06% | 4,126,470 | high |
| Jan 11, 2022 | General Atlantic LLC 10% owner | Buy Open-market buy | Common Stock | $27.20M | +1.7M +70.06% | 4,126,470 | high |
| Aug 11, 2022 | Sofinnova Venture Partners X, L.P. 10% owner | Buy Open-market buy | Common Stock | $15.00M | +500K +8.97% | 6,073,949 | high |
| Aug 11, 2022 | Healy James Director | Buy Open-market buy | Common Stock | $15.00M | +500K +8.97% | 6,073,949 | high |
| Aug 15, 2022 | 5AM Partners VI, LLC 10% owner | Buy Open-market buy | Common Stock | $14.62M | +487K | 487,333 | high |
| Jan 11, 2022 | Sofinnova Venture Partners X, L.P. 10% owner | Buy Open-market buy | Common Stock | $5.20M | +325K +6.19% | 5,573,949 | high |
| Jan 11, 2022 | Healy James Director | Buy Open-market buy | Common Stock | $5.20M | +325K +6.19% | 5,573,949 | high |
| Jan 11, 2022 | 5AM Partners VI, LLC 10% owner | Buy Open-market buy | Common Stock | $5.00M | +313K +170.00% | 496,323 | high |